MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
Crossref DOI link: https://doi.org/10.1186/s12906-017-2036-1
Published Online: 2017-12-15
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hwang, Ji Hye
Kang, Seok Yong
Kang, An Na
Jung, Hyo Won
Jung, Chul
Jeong, Jin-Ho
Park, Yong-Ki
Funding for this research was provided by:
Ministry of Health and Welfare (HI16C0622)
